Showing results 1 to 20 of 86
next >
| Issue Date | Title | Involved Person(s) |
| Jan-2023 | A novel surface functionalization platform to prime extracellular vesicles for targeted therapy and diagnostic imaging | Sabani, Besmira; Brand, Michael; Albert, Ina; Inderbitzin, Joelle; Eichenseher, Fritz, et al |
| 30-May-2018 | A Structural view on medicinal chemistry strategies against drug resistance | Agnello, Stefano; Brand, Michael; Chellat, Mathieu; Gazzola, Silvia; Riedl, Rainer |
| 2016 | Antibiotikaresistenzen gezielt überwinden | Chellat, Mathieu F.; Raguž, Luka; Riedl, Rainer |
| 11-Jul-2018 | Antiprotozoal compounds | Agnello, Stefano; Adams, Michael; Kaiser, Marcel; Mäser, Pascal; Urban, Alexander, et al |
| 17-Mar-2021 | Antiprotozoal structure–activity relationships of synthetic leucinostatin derivatives and elucidation of their mode of action | Brand, Michael; Wang, Lei; Agnello, Stefano; Gazzola, Silvia; Gall, Flavio, et al |
| 2021 | Antiprotozoische Struktur‐Aktivitäts‐Beziehungen von synthetischen Leucinostatin‐Derivaten und Aufklärung ihres Wirkprinzips | Brand, Michael; Wang, Lei; Agnello, Stefano; Gazzola, Silvia; Gall, Flavio, et al |
| 18-Jan-2021 | Antiviral screen against canine distemper virus-induced membrane fusion activity | Shrestha, Neeta; Gall, Flavio; Vesin, Jonathan; Chambon, Marc; Turcatti, Gerardo, et al |
| 10-Jun-2019 | Approaching target selectivity by de novo drug design | Fischer, Thomas; Gazzola, Silvia; Riedl, Rainer |
| 19-Apr-2021 | Back Cover: Antiprotozoal structure–activity relationships of synthetic leucinostatin derivatives and elucidation of their mode of action (Angew. Chem. Int. Ed. 28/2021) | Brand, Michael; Wang, Lei; Agnello, Stefano; Gazzola, Silvia; Gall, Flavio M., et al |
| 16-Dec-2022 | Bovine neutrophil chemotaxis to Listeria monocytogenes in neurolisteriosis depends on microglia-released rather than bacterial factors | Bagatella, Stefano; Haghayegh Jahromi, Neda; Monney, Camille; Polidori, Margherita; Gall, Flavio Max, et al |
| 2013 | Bridging the disciplines : cancer diagnostics & treatment | Riedl, Rainer |
| 14-Sep-2020 | Challenges with matrix metalloproteinase inhibition and future drug discovery avenues | Fischer, Thomas; Riedl, Rainer |
| 2012 | chemf : a purely functional chemistry toolkit | Höck, Stefan; Riedl, Rainer |
| 2000 | Combinatorial de novo synthesis of catalysts : how much of a hit-structure is needed for activity? | Berkessel, Albrecht; Riedl, Rainer |
| 9-Dec-2015 | Composition for treatment of pathogens that are resistant to tetracyclines | Schneider, Peter; Riedl, Rainer; Tigges, Marcel; Gitzinger, Marc; Pieren, Michel, et al |
| 18-Feb-2019 | Cover picture : drug design inspired by nature : crystallographic detection of an auto‐tailored protease inhibitor template (Angew. Chem. Int. Ed. 12/2019) | Gall, Flavio; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E., et al |
| 2017 | Cover picture : targeted fluoro positioning for the discovery of a potent and highly selective matrix metalloproteinase inhibitor (ChemistryOpen 2/2017) | Fischer, Thomas; Riedl, Rainer |
| 25-Feb-2015 | Cover Picture: Merging allosteric and active site binding motifs : de novo generation of target selectivity and potency via natural‐product‐derived fragments (ChemMedChem 3/2015) | Lanz, Jan; Riedl, Rainer |
| 2017 | Cover profile : targeted fluoro positioning for the discovery of a potent and highly selective matrix metalloproteinase inhibitor | Fischer, Thomas; Riedl, Rainer |
| 29-Feb-2020 | Cryo-EM structure of the prefusion state of canine distemper virus fusion protein ectodomain | Kalbermatter, David; Shrestha, Neeta; Gall, Flavio; Wyss, Marianne; Riedl, Rainer, et al |
